Results 181 to 190 of about 93,717 (263)

Influence of MASLD and MAFLD on long‐term extrahepatic cancer incidence and cancer mortality in regional Australia

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background and Aims Metabolic (dysfunction)‐associated steatotic liver disease (MASLD) has been linked to an increased risk of extrahepatic cancers. Whether MASLD or metabolic (dysfunction)‐associated fatty liver disease (MAFLD) is associated with an increased risk of extrahepatic cancer incidence or death in Australia is unknown. Methods This
Karl Vaz   +8 more
wiley   +1 more source

Prediction of incident heart failure in type 2 diabetes mellitus: Rationale and design of the DM‐HEART study

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Preclinical heart failure (HF) (stages A and B) is common but easily overlooked in asymptomatic patients with type 2 diabetes (T2D). There is a paucity of evidence regarding how coexisting risk factors contribute to the development of HF in asymptomatic Asian patients with T2D, and there is a lack of guidance on the early identification of ...
Jiun‐Lu Lin   +9 more
wiley   +1 more source

Association between blood pressure levels and mortality in patients with type 2 diabetes: A retrospective cohort analysis

open access: yesJournal of Diabetes Investigation, EarlyView.
In this retrospective cohort analysis, systolic blood pressure ≥140 mmHg (vs <130) significantly increased all‐cause, cardiovascular, cerebrovascular, and diabetes mortality, whereas diastolic pressure 80–90 mmHg (vs <80) was associated with lower all‐cause and cardiovascular mortality.
Zhen‐Yu Liu   +6 more
wiley   +1 more source

Elevated serum galectin‐3 levels predict the incidence of type 2 diabetes mellitus in a Japanese general population: A 10‐year follow‐up study

open access: yesJournal of Diabetes Investigation, EarlyView.
Elevated serum galectin‐3 levels are associated with the incidence of T2DM independent of insulin resistance, particularly among non‐obese individuals. There may be a diabetogenic mechanism that is not mediated by obesity or insulin resistance. ABSTRACT Aims/Introduction Although several studies have reported elevated serum galectin‐3 levels in type 2 ...
Harumi Takubo‐Yoshimura   +8 more
wiley   +1 more source

Taiwanese consensus statement on the use of diabetes‐specific formula: Scientific evidence

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Introduction Medical Nutrition Therapy remains the cornerstone of diabetes management. Clinical evidence shows that early intervention with medical nutrition therapy can significantly improve cardiometabolic markers, thereby delaying or preventing diabetes‐related complications.
Chih‐Hsun Chu   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy